4. Functional Neuroimaging of the Acute Effects of Drugs of Abuse

  1. Bryon Adinoff3,4 and
  2. Elliot A. Stein5
  1. Laurence John Reed1 and
  2. David J. Nutt2

Published Online: 2 NOV 2011

DOI: 10.1002/9781119998938.ch4

Neuroimaging in Addiction

Neuroimaging in Addiction

How to Cite

Reed, L. J. and Nutt, D. J. (2011) Functional Neuroimaging of the Acute Effects of Drugs of Abuse, in Neuroimaging in Addiction (eds B. Adinoff and E. A. Stein), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781119998938.ch4

Editor Information

  1. 3

    Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA

  2. 4

    VA North Texas Health Care System, Dallas, TX, USA

  3. 5

    National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA

Author Information

  1. 1

    Neuropsychopharmacology Unit, Centre for Pharmacology and Therapeutics, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK

  2. 2

    Neuropsychopharmacology Unit, Imperial College London, London, UK

Publication History

  1. Published Online: 2 NOV 2011
  2. Published Print: 9 NOV 2011

ISBN Information

Print ISBN: 9780470660140

Online ISBN: 9781119998938



  • functional neuroimaging, drugs of abuse;
  • ‘abuse liability’ of substance;
  • regulatory, public health perspective;
  • movement per se, reinforced behavior;
  • psychostimulant-induced dopamine release;
  • psychostimulants on dopaminergic function;
  • cannabis, abused illicit drugs;
  • opioid, functional neuroimaging;
  • “within-system” and “between-system” effects


This chapter contains sections titled:

  • Introduction

  • Fundamental Neuronal Systems Related to Abuse Liability in Humans

  • Psychostimulants

  • Alcohol

  • Cannabis and the Cannabinoids

  • Opioids

  • Conclusions and Future Directions

  • References